cs.CVApr 2, 2026

A deep learning pipeline for PAM50 subtype classification using histopathology images and multi-objective patch selection

Authors: Arezoo Borji, Gernot Kronreif, Bernhard Angermayr, Francisco Mario Calisto, Ali Abbasian Ardakani, Wolfgang Birkfellner, Inna Servetnyk, Yinyin Yuan, 

Organizations: Austrian Center for Medical Innovation and Technology, Wiener Neustadt, Austria · Department of Medicine, Faculty of Medicine and Dentistry, Danube Private University, Krems an der Donau, Austria. · Department of Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria · Patho im Zentrum, Saint Pölten, Austria · 

Abstract

Breast cancer is a highly heterogeneous disease with diverse molecular profiles. The PAM50 gene signature is widely recognized as a standard for classifying breast cancer into intrinsic subtypes, enabling more personalized treatment strategies. In this study, we introduce a novel optimization-driven deep learning framework that aims to reduce reliance on costly molecular assays by directly predicting PAM50 subtypes from H&E-stained whole-slide images (WSIs). Our method jointly optimizes patch informativeness, spatial diversity, uncertainty, and patch count by combining the non-dominated sorting genetic algorithm II (NSGA-II) with Monte Carlo dropout-based uncertainty estimation. The proposed method can identify a small but highly informative patch subset for classification. We used a ResNet18 backbone for feature extraction and a custom CNN head for classification. For evaluation, we used the internal TCGA-BRCA dataset as the training cohort and the external CPTAC-BRCA dataset as the test cohort. On the internal dataset, an F1-score of 0.8812 and an AUC of 0.9841 using 627 WSIs from the TCGA-BRCA cohort were achieved. The performance of the proposed approach on the external validation dataset showed an F1-score of 0.7952 and an AUC of 0.9512. These findings indicate that the proposed optimization-guided, uncertainty-aware patch selection can achieve high performance and improve the computational efficiency of histopathology-based PAM50 classification compared to existing methods, suggesting a scalable imaging-based replacement that has the potential to support clinical decision-making.

Explore similar work

CardsList
  1. Histo-MExNet: A Unified Framework for Real-World, Cross-Magnification, and Trustworthy Breast Cancer Histopathology

    Mar 15, 2026Enam Ahmed Taufika, Md Ahasanul Arafatha, Abhijit Kumar Ghoshb +2Histopathology Image ClassificationExplainable Medical Image Analysis

  2. Benchmarking Pathology Foundation Models for Breast Cancer Survival Prediction

    Apr 27, 2026Fredrik K. Gustafsson, Constance Boissin, Johan Vallon-Christersson +2Cancer Survival PredictionSurvival Analysis